Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigious | ||
Readability |
H.S. senior Avg
|
New words:
aim, allocation, America, ASU, atezolizumab, bearing, capacity, certainty, Certificate, certification, construct, consumed, consuming, Delaware, detailed, disaggregated, dollar, entity, erlotinib, exhausted, FASB, forward, full, greater, HCW, important, inducement, insight, likelihood, lipoplex, lower, manual, nominal, nonclinical, onetime, osimertinib, outcome, passing, pembrolizumab, permanent, person, play, purpose, ratio, reconciliation, restated, retroactive, role, Ryan, Secretary, segment, serve, served, serving, submitted, subscription, suppression, team, Topic, vendor, vital, withheld
Removed:
AACR, accumulation, adding, American, animal, apply, ATTD, attestation, audit, auditor, backlog, baseline, Berlin, cashback, closely, comply, complying, Conference, counsel, credit, deleted, documented, emerging, enacted, encapsulated, finalize, firm, generic, Germany, glucose, growing, harm, highlighting, human, humanized, immunity, implementation, improved, International, irrevocably, lipid, located, maintained, maintaining, manage, mandatory, measure, metastatic, monitor, mouse, nanoparticle, Notwithstanding, operation, positive, private, produced, promise, protocol, relevant, rely, requirement, requiring, resistant, rotation, solid, statistically, tolerance, toxicology, unit, waning, workforce, world
Filing tables
Filing exhibits
GNPX similar filings
Filing view
External links